Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022
Hyperfine, Inc. (Nasdaq: HYPR) will announce its financial results for Q2 2022 on August 10, 2022, at a webcast starting at 1:30 p.m. PT / 4:30 p.m. ET. The company is known for Swoop®, the first FDA-cleared portable MRI system, aimed at enhancing patient access to critical imaging. Designed for versatility, Swoop provides rapid diagnostics in various settings, with high-quality images at lower costs.
- Swoop® is the first FDA-cleared portable MRI system, addressing patient access to imaging.
- The system produces high-quality images quickly, enhancing decision-making in emergency settings.
- None.
GUILFORD, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it will report financial results for the second quarter 2022 on Wednesday, August 10, 2022. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Those interested in listening to the audio webcast should register online here. Participants are encouraged to register more than 15 minutes before the start of the call. A live audio webcast and an archive of the presentation will be available through the Investors page of Hyperfine’s corporate website at https://investors.hyperfine.io/.
About Hyperfine
Hyperfine, Inc. is the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™. Hyperfine designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System™ produces high-quality images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose, and treat patients in various clinical settings. Swoop can be wheeled directly to the patient’s bedside, plugged into a standard electrical wall outlet, and controlled by an iPad®. Designed as a complementary system to conventional MRIs at a fraction of the cost, Swoop captures images in minutes, providing critical decision-making capabilities in emergency departments, operating rooms outside the sterile field, and intensive care units, among others.
Investor Contact
Marissa Bych
Gilmartin Group LLC
investors@hyperfine.io
FAQ
When will Hyperfine announce its Q2 2022 financial results?
What is Swoop® from Hyperfine?
What time is Hyperfine's Q2 2022 earnings webcast?
How can I listen to Hyperfine's financial results call?
